bluebird (BLUE) Q2 Loss Narrower Than Expected, Sales Miss

This article was originally published on Nasdaq

bluebird bio, Inc. BLUE reported an adjusted loss of $1.27 per share (excluding restructuring charges) from continued operations in the second quarter of 2022, narrower than the Zacks Consensus Estimate of a loss of $1.31. In the year-ago quarter, BLUE posted a loss of $2

Responses